Secondary polycythaemia

D3_SCNDPOLYCYTHAEMIA

polycythemia: Abnormally high mass or concentration of red blood cells in the blood, either due to an increase in erythropoiesis or a decrease in plasma volume.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

473681

1. Apply sex-specific rule

None

473681

2. Check conditions

None

473681

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D75.1
  • Hospital discharge: ICD-9 2890
  • Hospital discharge: ICD-8 28900
  • Cause of death: ICD-10 D75.1
  • Cause of death: ICD-9 2890
  • Cause of death: ICD-8 28900

2 out of 7 registries used, show all original rules.

762

4. Check minimum number of events

None

762

5. Include endpoints

None

762

6. Filter based on genotype QC (FinnGen only)

735

Control definitions (FinnGen only)

Control exclude D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D75
Name in latin Polycythaemia secundaria

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5793 1925 3795
Only index persons 4662 1564 3098
Unadjusted period prevalence (%)
Whole population 0.09 0.06 0.11
Only index persons 0.10 0.06 0.12
Median age at first event (years)
Whole population 58.75 60.79 57.65
Only index persons 57.47 60.07 56.16

-FinnGen-

Key figures

All Female Male
Number of individuals 735 248 487
Unadjusted period prevalence (%) 0.19 0.10 0.24
Median age at first event (years) 58.02 56.76 58.67

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Mortality – FinRegistry

Association

Association between endpoint D3_SCNDPOLYCYTHAEMIA and mortality.

Females

Parameter HR [95% CI] p-value
D3_SCNDPOLYCYTHAEMIA 2.337 [1.94, 2.81] < 0.001
Birth year 0.998 [0.99, 1.01] 0.556

During the follow-up period (1.1.1998 — 31.12.2019), 330 out of 1298 females with D3_SCNDPOLYCYTHAEMIA died.

Males

Parameter HR [95% CI] p-value
D3_SCNDPOLYCYTHAEMIA 1.929 [1.65, 2.25] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 574 out of 2522 males with D3_SCNDPOLYCYTHAEMIA died.

Mortality risk

Mortality risk for people of age

years, who have D3_SCNDPOLYCYTHAEMIA.

N-year risk Females Males
1 0.314% 0.369%
5 1.509% 2.132%
10 3.477% 5.162%
15 6.641% 10.023%
20 12.368% 16.089%

Relationships between endpoints

Index endpoint: D3_SCNDPOLYCYTHAEMIA – Secondary polycythaemia

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data